CoTox/88_propranolol.json at main · dmis-lab/CoTox · GitHub

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
{
    "Toxicity Predictions": {
        "Cardiotoxicity": {
            "Reasoning": [
                "Pathway: The provided pathways, such as 'Intrinsic Pathway for Apoptosis' and 'Activation of caspases', describe general cell death mechanisms that can be triggered in cardiomyocytes under stress. While no specific cardiac pathways are listed, severe cellular stress resulting from the drug's primary pharmacological action can lead to apoptosis.",
                "GO Term: General GO terms like 'positive regulation of oxidative stress-induced cell death' can apply to cardiac tissue. Oxidative stress is a known factor in the pathophysiology of various heart conditions, and the compound's metabolism can induce such stress.",
                "IUPAC Support: The structure, 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol, is a classic non-selective beta-blocker. The propanolamine side chain is responsible for binding to beta-adrenergic receptors in the heart. The primary mechanism of cardiotoxicity is pharmacological, stemming from excessive blockade of these receptors.",
                "Overall Mechanism: As a beta-blocker, the compound reduces heart rate and contractility. At toxic doses, this leads to severe bradycardia, hypotension, and potentially cardiogenic shock. This profound physiological stress can secondarily trigger apoptotic pathways in cardiomyocytes, leading to cell death and contributing to cardiac failure."
            ],
            "Prediction": "Toxic"
        },
        "Hematological Toxicity": {
            "Reasoning": [
                "Pathway: The extensive list of apoptosis-related pathways, including 'SMAC-mediated apoptotic response' and 'Apoptotic cleavage of cellular proteins', indicates a strong potential to induce programmed cell death in susceptible cell populations, including hematopoietic cells.",
                "GO Term: The term 'B cell apoptotic process' provides direct and specific evidence that the compound can trigger apoptosis in B lymphocytes, a key component of the adaptive immune system.",
                "IUPAC Support: The lipophilic naphthalene moiety facilitates the compound's entry into various cells, including lymphocytes. Once inside, the molecule can interact with intracellular targets to initiate the apoptotic cascade identified by the pathway and GO term analyses.",
                "Overall Mechanism: The compound is taken up by B lymphocytes and initiates the intrinsic apoptotic pathway. This is strongly supported by the specific 'B cell apoptotic process' GO term and the numerous general apoptosis pathways. The resulting depletion of B cells can lead to immunosuppression and other hematological abnormalities."
            ],
            "Prediction": "Toxic"
        },
        "Infertility": {
            "Reasoning": [
                "Pathway: The provided pathways are general and not specific to reproductive toxicology. Pathways related to apoptosis could theoretically affect germ cells, but there is no direct evidence of this.",
                "GO Term: None of the provided GO terms are related to reproductive function, gamete production, or the endocrine system that regulates fertility.",
                "IUPAC Support: The chemical structure does not contain features typically associated with reproductive toxicants, such as steroid hormone mimics or alkylating agents that directly damage germ cell DNA.",
                "Overall Mechanism: Based on the available pathway and GO term data, there is no evidence to construct a plausible mechanism for infertility. The data does not point to any specific interaction with the reproductive system."
            ],
            "Prediction": "Non-Toxic"
        },
        "Liver Toxicity": {
            "Reasoning": [
                "Pathway: The 'CYP2E1 reactions' and 'Xenobiotics' pathways are direct indicators of liver toxicity. CYP2E1 metabolism is known to generate reactive oxygen species (ROS) and toxic metabolites, which then trigger the 'Intrinsic Pathway for Apoptosis' and 'Cytochrome c-mediated apoptotic response' in hepatocytes.",
                "GO Term: The terms 'xenobiotic catabolic process', 'toxin metabolic process', and 'positive regulation of oxidative stress-induced cell death' corroborate the pathway analysis, describing the breakdown of the compound in a manner that leads to oxidative stress and cell death.",
                "IUPAC Support: The naphthalene ring is a polycyclic aromatic hydrocarbon (PAH) moiety. Metabolism of such structures by P450 enzymes like CYP2E1 can form reactive epoxide intermediates. These intermediates can deplete cellular glutathione, bind to proteins and DNA, and cause severe oxidative stress, leading to hepatocyte death.",
                "Overall Mechanism: The compound is transported to the liver, where it undergoes metabolism by the CYP2E1 enzyme system. This process generates highly reactive metabolites from the naphthalene ring, inducing significant oxidative stress. This overwhelms the hepatocyte's antioxidant defenses, triggering the intrinsic apoptotic pathway, leading to cell death and drug-induced liver injury (DILI)."
            ],
            "Prediction": "Toxic"
        },
        "Pulmonary Toxicity": {
            "Reasoning": [
                "Pathway: The provided pathways do not directly relate to pulmonary function. The toxicity mechanism is primarily pharmacological rather than cytotoxic, and thus not captured by the listed apoptosis pathways.",
                "GO Term: No GO terms specific to lung or respiratory function are provided. The general cell death terms are not specific enough to predict pulmonary toxicity without other supporting information.",
                "IUPAC Support: The structure is that of a non-selective beta-blocker. The propanolamine side chain binds to both beta-1 (cardiac) and beta-2 (pulmonary) adrenergic receptors. Blockade of beta-2 receptors in the bronchial smooth muscle antagonizes bronchodilation.",
                "Overall Mechanism: The compound's toxicity in the lungs is a direct result of its pharmacological action. By blocking beta-2 adrenergic receptors, it prevents the relaxation of airway smooth muscle. In individuals with pre-existing conditions like asthma or COPD, this can lead to severe, life-threatening bronchoconstriction."
            ],
            "Prediction": "Toxic"
        },
        "Renal Toxicity": {
            "Reasoning": [
                "Pathway: No pathways specific to renal function, such as tubular transport or glomerular filtration, are listed. The general apoptosis pathways lack specific evidence linking them to kidney damage.",
                "GO Term: There are no GO terms related to the kidney (e.g., nephron development, renal transport, urine formation). The xenobiotic transport terms are general and do not specifically implicate renal transporters in a toxic mechanism.",
                "IUPAC Support: The structure does not possess functional groups that are classic structural alerts for nephrotoxicity (e.g., aminoglycosides, platinum-containing compounds).",
                "Overall Mechanism: The provided data from pathways and GO terms offers no evidence to suggest a mechanism for renal toxicity. While the compound and its metabolites are excreted renally, there is no indication that this process causes direct damage to kidney cells."
            ],
            "Prediction": "Non-Toxic"
        }
    },
    "Final_Answer_List": [
        1,
        1,
        0,
        1,
        1,
        0
    ],
    "True_Answer_List": [
        1,
        1,
        0,
        1,
        1,
        0
    ]
}